These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 22524470

  • 1. Factors associated with positive F-18 flurodeoxyglucose positron emission tomography before thyroidectomy in patients with papillary thyroid carcinoma.
    Kim BS, Kim SJ, Kim IJ, Pak K, Kim K.
    Thyroid; 2012 Jul; 22(7):725-9. PubMed ID: 22524470
    [Abstract] [Full Text] [Related]

  • 2. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Kang JH, Jung DW, Pak KJ, Kim IJ, Kim HJ, Cho JK, Shin SC, Wang SG, Lee BJ.
    Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
    [Abstract] [Full Text] [Related]

  • 3. Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on 18F-FDG PET/CT in Patients with Papillary Thyroid Carcinoma.
    Jung JH, Kim CY, Son SH, Kim DH, Jeong SY, Lee SW, Lee J, Ahn BC.
    PLoS One; 2015 Jan; 10(12):e0144152. PubMed ID: 26636824
    [Abstract] [Full Text] [Related]

  • 4. Feasibility of FDG-PET/CT for the initial diagnosis of papillary thyroid cancer.
    Kim H, Na KJ, Choi JH, Ahn BC, Ahn D, Sohn JH.
    Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1569-76. PubMed ID: 25971994
    [Abstract] [Full Text] [Related]

  • 5. Analysis of predictability of F-18 fluorodeoxyglucose-PET/CT in the recurrence of papillary thyroid carcinoma.
    Kim SK, So Y, Chung HW, Yoo YB, Park KS, Hwang TS, Kim B, Lee WW.
    Cancer Med; 2016 Oct; 5(10):2756-2762. PubMed ID: 27539659
    [Abstract] [Full Text] [Related]

  • 6. PROGNOSTIC VALUE OF LYMPH NODE UPTAKE ON PRETREATMENT F-18 FDG PET/CT IN PATIENTS WITH N1B PAPILLARY THYROID CARCINOMA.
    Lee CH, Lee SW, Son SH, Hong CM, Jeong JH, Jeong SY, Ahn BC, Lee J.
    Endocr Pract; 2019 Aug; 25(8):787-793. PubMed ID: 31013158
    [Abstract] [Full Text] [Related]

  • 7. Non-FDG-avid primary papillary thyroid carcinoma may not differ from FDG-avid papillary thyroid carcinoma.
    Kim MH, Ko SH, Bae JS, Lee SH, Jung CK, Lim DJ, Baek KH, Kim SH, Lee JM, Kang MI, Cha BY.
    Thyroid; 2013 Nov; 23(11):1452-60. PubMed ID: 23688271
    [Abstract] [Full Text] [Related]

  • 8. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
    Dennis K, Hay JH, Wilson DC.
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
    [Abstract] [Full Text] [Related]

  • 9. Clinical value of visually identifiable 18F-fluorodeoxyglucose uptake in primary papillary thyroid microcarcinoma.
    Hwang SO, Lee SW, Kang JK, Choi HH, Kim WW, Park HY, Jung JH.
    Otolaryngol Head Neck Surg; 2014 Sep; 151(3):415-20. PubMed ID: 24903453
    [Abstract] [Full Text] [Related]

  • 10. Prediction of central lymph node metastasis from papillary thyroid microcarcinoma by 18F-fluorodeoxyglucose PET/CT and ultrasonography.
    Byun BH, Jeong UG, Hong SP, Min JJ, Chong A, Song HC, Bom HS.
    Ann Nucl Med; 2012 Jul; 26(6):471-7. PubMed ID: 22467230
    [Abstract] [Full Text] [Related]

  • 11. Fluorodeoxyglucose-positron emission tomography scan-positive recurrent papillary thyroid cancer and the prognosis and implications for surgical management.
    Schreinemakers JM, Vriens MR, Munoz-Perez N, Guerrero MA, Suh I, Rinkes IH, Gosnell J, Shen WT, Clark OH, Duh QY.
    World J Surg Oncol; 2012 Sep 17; 10():192. PubMed ID: 22985118
    [Abstract] [Full Text] [Related]

  • 12. Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma.
    Frilling A, Tecklenborg K, Görges R, Weber F, Clausen M, Broelsch EC.
    Ann Surg; 2001 Dec 17; 234(6):804-11. PubMed ID: 11729387
    [Abstract] [Full Text] [Related]

  • 13. [Diagnostic values of ultrasound and (18)F-fluoro-2-deoxy-D-glucose-positron emission tomography/computerized tomography for patients with suspected thyroid carcinoma and lymph node metastasis].
    Lai XJ, Zhang B, Jiang YX, Dai Q, Zhao RN.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug 17; 35(4):393-7. PubMed ID: 23987485
    [Abstract] [Full Text] [Related]

  • 14. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
    Ozkan E, Soydal C, Kucuk ON, Ibis E, Erbay G.
    Nucl Med Commun; 2011 Dec 17; 32(12):1162-8. PubMed ID: 21946617
    [Abstract] [Full Text] [Related]

  • 15. Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
    Weber T, Ohlhauser D, Hillenbrand A, Henne-Bruns D, Reske SN, Luster M.
    Horm Metab Res; 2012 Nov 17; 44(12):904-8. PubMed ID: 22791600
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic Capabilities of MRI Versus 18F FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, 131I-negative Local Recurrent or Metastatic Thyroid Cancer.
    Samanci C, Onal Y, Sager S, Asa S, Ustabasioglu FE, Alis D, Akman C, Sonmezoglu K.
    Curr Med Imaging Rev; 2019 Nov 17; 15(10):956-964. PubMed ID: 32008523
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus.
    Kim JW, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2013 May 17; 49(5):449-53. PubMed ID: 23321549
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies.
    Nakajo M, Nakajo M, Jinguji M, Tani A, Kajiya Y, Tanabe H, Fukukura Y, Nakabeppu Y, Koriyama C.
    Radiology; 2013 Jun 17; 267(3):891-901. PubMed ID: 23468571
    [Abstract] [Full Text] [Related]

  • 19. Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.
    Sabet A, Binse I, Grafe H, Ezziddin S, Görges R, Poeppel TD, Bockisch A, Rosenbaum-Krumme SJ.
    Eur J Nucl Med Mol Imaging; 2016 Oct 17; 43(11):1988-94. PubMed ID: 27118127
    [Abstract] [Full Text] [Related]

  • 20. Visually discernible [18F]fluorodeoxyglucose uptake in papillary thyroid microcarcinoma: a potential new risk factor.
    Yun M, Noh TW, Cho A, Choi YJ, Hong SW, Park CS, Lee JD, Kim CK.
    J Clin Endocrinol Metab; 2010 Jul 17; 95(7):3182-8. PubMed ID: 20427505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.